Sponsors Investigators Should Question & Answer Guide (With Explanation)
This question focuses on applying theory to practical scenarios.
What This Question Is About
This question relates to sponsors investigators should and requires a structured academic response.
How to Approach This Question
Focus on explaining concepts clearly and supporting them with examples.
Key Explanation
This topic involves sponsors investigators should. A strong answer should include explanation, application, and examples.
Original Question
8) Sponsors, investigators and IRB/IEC’s should be aware that unique privacy risks-may arise when DHTs are used in Clinical investigations. Which of the following should be considered? A) Safeguards are in place to prevent access by malicious parties B) Cost of ensuring cybersecurity C) Compatibility of hardware platforms D) Frequency of backup of data 9) To help ensure the quality and integrity of data, adequate protection of participants, and satisfaction of regulatory requirements applicable to clinical investigations, sponsors should consider which of the following for investigations that involve use of DHTs? A) The budget to include the cost of the DHT tool B) A risk management plan to address potential problems participants may experience when using the DHT C) Reviewing IRB/IEC membership and frequency of review D) All of the above 10) To help ensure the quality and integrity of data, adequate protection of participants and satisfaction of regulatory requirements applicable to clinical investigations, investigators should consider which of the following for investigations that involve the use of DHTs? A) Ensuring trial participants understand how the information will be used B) Development of the clinical investigation’s budget C) Reporting of adverse effects from DHTs to the FDA D) All of the above
******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."